Search over 3,000 reports

    Endometriosis - Market Insights, Epidemiology and Market Forecast-2023

    Endometriosis - Market Insights, Epidemiology and Market Forecast-2023
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 85
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0010
    DelveInsight's "Endometriosis - Market Insights, Epidemiology and Market Forecast-2023"
    Report provides an overview of the disease and global market size of the Endometriosis for the
    7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes
    global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable
    cases of Endometriosis from 2013-2023.
    Endometriosis is the abnormal growth of endometrial tissue similar to that which lines the
    interior of the uterus, but in a location outside of the uterus. It is usually developed in
    Peritoneum, fallopian tubes, Ovaries, Cul-de-sac (the space behind the uterus), Outer surfaces
    of the uterus, bladder, ureters, intestines, and rectum.
    Worldwide in 2012, 527,600 women were diagnosed with Endometriosis. The mortality rate
    was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries
    Endometriosis was the most common gynecologic malignancy, with over 60,000 new cases and
    over 10,000 deaths from the disease in each year.
    Lupron, developed by Abbvie is the top selling drug of Endometriosis contributing to majority of
    the market size. Other top players include Visanne/Dienogest (Bayer Healthcare), Zoladex
    (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer). According to DelveInsight, the
    worldwide Endometriosis market is estimated to be USD 1.91 Billion by 2023 at a CAGR of
    1.33%.
    The report is built using data and information sourced from proprietary databases, primary and
    secondary research and in-house Forecast model analysis by Publisher team of industry experts.
    Scope
    - Report covers the disease overview including pathophysiology, symptoms, diagnosis,
    disease management, and current treatment options.
    - Marketed information including available prescription drugs, its patent and exclusivity
    details.
    - The Report also covers the detailed global historical and forecasted epidemiological data
    covering United States, EU5 and Japan from 2013-2023.
    - It also provides Market size of Endometriosis for United States, EU5 and Japan from
    2013 and forecasted Market size to 2023.
    Report Introduction
    Endometriosis Market Overview at a Glance
    Global Market Size of Endometriosis in 2015
    Global Market Size of Endometriosis in 2023
    Endometriosis
    • Overview
    • Stages
    • Types
    • Pathophysiology
    • Risk Factors
    • Diagnosis
    • Treatment
    Epidemiology of Endometriosis in 7MM
    • United States
    • EU5
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Japan
    Treatment Algorithm
    Initial Treatment
    Treatment of Recurrent Endometriosis
    Add-Back Therapy
    Current Unmet Needs
    Marketed Drugs
    Lupron
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Depo-SubQ Provera 104
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Visanne
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Zoladex
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Synarel
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Pamorelin/Decapeptyl/Trelstar
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Emerging Therapies
    Elagolix: AbbVie Inc
    Description
    Regulatory Milestones
    Clinical Development
    Product Profile
    Clinical Trial by Phase
    Safety and Efficacy
    Femitra: EndoCeutics Inc
    Description
    Product Profile
    BAY 86-5300: Bayer HealthCare Pharmaceuticals
    Description
    Clinical Development
    Product Profile
    Clinical Trial by Phase
    Global Endometriosis: Country-Wise Market Analysis
    Total Market Size of Endometriosis (2013-2023)
    • United States
    • EU5
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Japan
    Market Drivers
    Market Barriers
    Appendix
    Report Methodology
    Consulting Services
    Disclaimer
    About DelveInsight
    Table 1: Prevalent, Diagnosed and Treatable cases of Endometriosis in United States (2013-2023)
    Table 2: Prevalent, Diagnosed and Treatable cases of Endometriosis in United Kingdom (2013-2023)
    Table 3: Prevalent, Diagnosed and Treatable cases of Endometriosis in Germany (2013-2023)
    Table 4: Prevalent, Diagnosed and Treatable cases of Endometriosis in France (2013-2023)
    Table 5: Prevalent, Diagnosed and Treatable cases of Endometriosis in Italy (2013-2023)
    Table 6: Prevalent, Diagnosed and Treatable cases of Endometriosis in Spain (2013-2023)
    Table 7: Prevalent, Diagnosed and Treatable cases of Endometriosis in Japan (2013-2023)
    Table 8: Total Market size of Endometriosis in USD Billion (2013-2023)
    Table 9: United States Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 10: United Kingdom Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 11: Germany Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 12: France Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 13: Italy Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 14: Spain Market Size of Endometriosis in USD, Billion (2013-2023)
    Table 15:Japan Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 1: Pathogenesis and Pathophysiology of Endometriosis
    Figure 2: Risk Factors associated with Endometriosis
    Figure 3: Treatment for endometriosis
    Figure 4: Prevalent Population of Endometriosis in United States (2013-2023)
    Figure 5: Prevalent, Diagnosed and Treatable cases of Endometriosis in United States (2013-2023)
    Figure 6: Prevalent Population of Endometriosis in United Kingdom (2013-2023)
    Figure 7: Prevalent, Diagnosed and Treatable cases of Endometriosis in United Kingdom (2013-2023)
    Figure 8: Prevalent Population of Endometriosis in Germany (2013-2023)
    Figure 9: Prevalent, Diagnosed and Treatable cases of Endometriosis in Germany (2013-2023)
    Figure 10: Prevalent Population of Endometriosis in France (2013-2023)
    Figure 11: Prevalent, Diagnosed and Treatable cases of Endometriosis in France (2013-2023)
    Figure 12: Prevalent Population of Endometriosis in Italy (2013-2023)
    Figure 13: Prevalent, Diagnosed and Treatable cases of Endometriosis in Italy (2013-2023)
    Figure 14: Prevalent Population of Endometriosis in Spain (2013-2023)
    Figure 15: Prevalent, Diagnosed and Treatable cases of Endometriosis in Spain (2013-2023)
    Figure 16: Prevalent Population of Endometriosis in Japan (2013-2023)
    Figure 17: Prevalent, Diagnosed and Treatable cases of Endometriosis in Japan (2013-2023)
    Figure 18: Treatment Algorithm, 2016
    Figure 19: Current Unmet Needs of Endometriosis
    Figure 20: Total Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 21: United States Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 22: United Kingdom Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 23: Germany Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 24: France Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 25: Italy Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 26: Spain Market Size of Endometriosis in USD, Billion (2013-2023)
    Figure 27:Japan Market Size of Endometriosis in USD, Billion (2013-2023)
    Endometriosis Market (7MM)

    Endometriosis Market forecasting

    Endometriosis Sales forecasting

    Endometriosis Market segments

    Endometriosis Epidemiology

    Endometriosis Pipeline products and technologies

    Endometriosis Competitive landscape

    Endometriosis SWOT analysis

    Endometriosis Market Driver's and barriers

    Endometriosis Key Companies and Funding

    • Single User License
      (20% Off)
      $4,950.00
      $3960
    • Site License
      (30% Off)
      $9,900.00
      $6930
    • Global License
      (40% Off)
      $14,850.00
      $8910

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap